|Dr. Michael P. Goldsworthy BSc (Hons), MSc, Ph.D., FAIP, GAICD||Chief Exec. Officer, Managing Director and Exec. Director||N/A||N/A||59|
|Ms. Julie E. Ducie B.Bus., CA, GAICD||Chief Financial Officer and Company Sec.||N/A||N/A||N/A|
|Dr. Andrew Clark B.Sc(Hons),Ph.D.||VP of Engineering - Translucent||N/A||N/A||N/A|
Silex Systems Limited engages in the research, development, commercialization, and licensing of technologies for uranium enrichment. The company primarily develops and commercializes SILEX technology, a laser isotope separation process to enrich uranium for use in nuclear power reactors. The company was founded in 1988 and is based in Sydney, Australia.
Silex Systems Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.